Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $4,131.8M | $5,363.0M | $5,954.7M | $4,960.6M | $4,942.6M | $4,833.2M | $4,481.5M | $4,407.9M | $4,687.1M | $5,098.9M | $5,358.1M | $5,419.1M | $4,985.2M | $5,837.0M | $6,733.0M | $7,711.0M | $8,946.0M | $8,451.0M | $8,745.0M | $137.2B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Elevance Health Inc.'s last 12-month Operating Income is $42.6B, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Elevance Health Inc.'s Operating Income growth was 386.8%. The average annual Operating Income growth rates for Elevance Health Inc. have been 88.5% over the past three years, 44.6% over the past five years.
Over the last year, Elevance Health Inc.'s Operating Income growth was 386.8%, which is higher than industry growth of (0.1%). It indicates that Elevance Health Inc.'s Operating Income growth is Good.